4-10B-Borono-2-18F-fluoro-l-phenylalanine (18F-FBPA) was developed for monitoring the pharmacokinetics of 4-10B-boronol-phenylalanine (10B-BPA) used in boron neutron capture therapy (BNCT) with positron emission tomography (PET).
A 52-year-old woman was diagnosed with leftparietalglioblastoma, and underwent craniotomy with near total tumor removal on October 11th, 2017.
報告台灣首例利用硼中子捕獲方式來治療復發性之顱內惡性膠質細胞瘤。
報告一例復發性耳下腺癌接受台灣首次硼中子捕獲治療臨床試驗的成果。
To investigate the efficacy and safety of boron neutron capture therapy(BNCT), we treated 17 patients with recurrent head and neck (H&N) cancer after photon radiation therapy in a prospective phase 1/2 trial started in 2010.
We treated a 54-year-old Japanese female with a recurrent radiation-induced osteosarcoma arising from left occipital skull, by reactor-based boron neutron capture therapy (BNCT).
Recurrent malignant gliomas (RMGs) are very difficult to control, and no standard treatments have been established for them
PMalignant meningioma is a rare brain tumor with a high risk of recurrence.
To introduce our experience of treating locally and regionally recurrent head and neck cancer patients with BNCT at Tsing Hua Open-Pool Reactor in Taiwan
从1895 年伦琴发现射线，1898年居里夫妇发现镭，1950年代开始钴唱60治疗以来，到现在放射线的医疗应用已经有近100年的历史。
⾃七零年代起，癌病因素即成為國⼈主要之致死原因，近年來，每年因癌病死亡之國⼈數已突破四萬⼈，國內外醫學界亦均以突破癌病治療為臨床及基礎研究之主要⽬標。
Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is a constituent of natural elemental boron, is irradiated with
放射治疗、手术及化学治疗是现代癌症治疗的三大支柱。在放射治疗领域，粒子治疗（particle therapy）是现今最受瞩目的治疗利器。
Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is a constituent of natural elemental boron, is irradiated with low energy thermal neutrons to yield high linear energy transfer alpha particles and recoiling lithium-7 nuclei. Clinical interest in BNCT has focused primarily on the treatment of high grade gliomas,
自七零年代起，癌病因素即成为国人主要之致死原因，近年来，每年因癌病死亡之国人数已突破四万人，国内外医学界亦均以突破癌病治疗为临床及基础研究之主要目标。